In the BioHarmony Drug Report Database
Tegaserod
Zelnorm (tegaserod) is a small molecule pharmaceutical. Tegaserod was first approved as Zelnorm on 2002-07-24. It is used to treat constipation and irritable bowel syndrome in the USA. It is known to target 5-hydroxytryptamine receptor 2B and 5-hydroxytryptamine receptor 4.
Trade Name
|
Zelnorm |
|---|---|
Common Name
|
tegaserod |
ChEMBL ID
|
CHEMBL76370 |
Indication
|
constipation, irritable bowel syndrome |
Drug Class
|
Serotonin receptor antagonists and partial agonists |
Image (chem structure or protein)